MedTrace Logo

Economic Evaluation of an Education Platform for Patients With End-stage Renal Disease

NCT03090828 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1600

Last updated 2017-03-27

No results posted yet for this study

Summary

1600 patients with severe, end stage renal disease or post transplant will be randomised 1:1:1 to either standard therapeutic education; or education using a specific app; or the enhanced interactive app using feedback messages.

The total follow up duration is 18 months. Primary endpoint is the cost utility of using app-based therapeutic intervention, secondary endpoints are: compliance with treatment guidelines, app use (professionals and patients), budget impact analysis

Conditions

  • End-stage Renal Disease
  • Dialysis
  • Kidney Transplantation

Interventions

BEHAVIORAL

app-based therapeutic education

Patients will connect to a platform providing information on end-stage renal disease and to contact health care providers.

BEHAVIORAL

enhanced app-based therapeutic education

Patients in the enhanced app group will also have access to a social network. (forum, chat room)

Sponsors & Collaborators

  • Centre Leon Berard

    collaborator OTHER

  • Université Montpellier

    collaborator OTHER

  • Telecom Bretagne

    collaborator UNKNOWN

  • Paris School of Economics

    collaborator UNKNOWN

  • Ministry of Health, France

    collaborator OTHER_GOV

  • Assistance Publique - Hôpitaux de Paris

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-09-30
Primary Completion
2021-03-31
Completion
2022-03-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03090828 on ClinicalTrials.gov